Todd C. Lee Md Mph Fidsa
Clinical trials sponsored by Todd C. Lee Md Mph Fidsa, explained in plain language.
-
Could less be more? major trial questions routine antibiotic for heart valve infections
Disease control Recruiting nowThis study looks at whether it is safe to not give the antibiotic rifampin to people with a serious heart valve infection caused by S. aureus bacteria. About 330 adults with infected artificial heart valves will be randomly assigned to receive either rifampin plus standard care o…
Phase: PHASE3 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated May 17, 2026 05:22 UTC
-
Could a common heart drug fight staph infections too?
Disease control Recruiting nowThis study looks at whether switching from aspirin to clopidogrel (another blood thinner) can reduce heart complications in people with a serious staph bloodstream infection. About 300 adults who already take aspirin for heart disease prevention will be randomly assigned to stay …
Phase: PHASE4 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated May 17, 2026 05:20 UTC
-
Could a lower dose of a standard pneumonia drug be safer and just as effective?
Disease control Recruiting nowThis study is for people with weakened immune systems who have a serious lung infection called PCP. The standard treatment often causes harsh side effects. Researchers want to see if a lower dose of the drug works just as well but with fewer side effects. About 416 adults will ta…
Phase: PHASE3 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated May 17, 2026 05:06 UTC
-
Which antibiotic wins against MRSA in the blood?
Disease control Recruiting nowThis study compares two common antibiotics, daptomycin and vancomycin, to see which one works better for people with a serious MRSA bloodstream infection. About 300 adults with MRSA in their blood will be randomly assigned to one of the two drugs. The goal is to find out which tr…
Phase: PHASE4 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New combo therapy aims to beat staph blood infections
Disease control Recruiting nowThis study tests whether adding ertapenem to the standard antibiotic cefazolin helps adults with a serious staph bloodstream infection (MSSA) recover faster. About 60 participants will receive either the combo or standard care. The goal is to see if the combination clears the inf…
Phase: PHASE2 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated May 14, 2026 12:01 UTC